#USA #Cancer Treatment #Global Health #NCCN #Montreal, Manila

Enhancing Global Cancer Care: NCCN's Collaborative Efforts

In an ambitious move to improve cancer care worldwide, the National Comprehensive Cancer Network® (NCCN®) has forged crucial partnerships with various international organizations. This initiative aims to tailor and publicize the NCCN Clinical Practice Guidelines in Oncology specifically for the Philippines. This was prominently showcased during the recent international conferences held in Montreal and Manila, indicating a clear commitment to advancing cancer treatment standards.

On October 1-3, 2026, NCCN actively participated in the International Gynecologic Cancer Society (IGCS) global annual meeting in Montreal, followed by a significant gathering with the Philippine Society of Medical Oncology (PSMO) and Department of Health from October 6-9 in Manila. These conferences provided a vital platform for discussing changes in cancer treatment protocols and the necessity for a globally unified approach to oncology.

According to Dr. Crystal S. Denlinger, CEO of NCCN, their collective endeavors are rooted in a shared passion for fostering access to effective cancer care. "Our joint efforts in the Philippines and beyond reflect a shared commitment to improving access to appropriate cancer care, reducing disparities in treatment, and strengthening oncology practice through proven guidance," she noted. This sentiment was echoed across the conferences, highlighting a collaborative approach that marries NCCN's extensive expertise with regional insights to form more applicable, evidence-based recommendations.

The adaptations of the NCCN Guidelines for the Philippines will address critical areas of concern, including:

• - B-Cell Lymphomas
• - Breast Cancer
• - Colon Cancer
• - Hepatocellular Carcinoma
• - Lung Cancer
• - Prostate Cancer
• - Rectal Cancer
• - Cervical Cancer
• - Ovarian Cancer
• - Uterine Cancer

Free access to these guidelines will soon be available at NCCN.org/global, promoting further engagement and adherence to evidence-driven practices. During the October 6th high-level meeting, a focused discussion on the integration of these localized guidelines into national health programs under the National Integrated Cancer Control Act (NICCA) took place. The meeting featured insights from Professor Jacek Jassem from Poland, who elaborated on successful implementations of NCCN guidelines in his country.

Statements from leading professionals emphasized the significance of developing guidelines that mirror local environments and regulations. Dr. Hiyasmin A. Alejandro, PSMO Vice President, articulated that this unique collaboration hands Filipino healthcare providers a structured framework that reflects both global and local practices, thus fostering consistent, quality, and equitable cancer care.

Moreover, Dr. Doris Benavides, immediate past president of SGOP, reinforced the importance of tailoring the NCCN Guidelines for specific cancers such as cervical, uterine, and ovarian cancers, ensuring a specialized approach grounded in local medical practices.

Following the success of these initiatives in the Philippines, NCCN has entered a new Memorandum of Understanding (MOU) with IGCS, signaling its intention to extend this model to other regions as well. Mary Eiken, CEO of IGCS, remarked on their commitment to enhancing gynecologic cancer care globally through education and collaborative efforts.

Presently, NCCN boasts over 90 international adaptations of these invaluable guidelines, highlighting its commitment to making quality cancer care accessible to a broader audience. For those interested in furthering their understanding of these global initiatives, visit NCCN.org/global for more information.

In conclusion, the NCCN's strategic collaborations signify a pivotal moment in the fight against cancer, with the potential to influence outcomes for patients worldwide positively. These efforts not only enhance local care delivery in the Philippines but also set a precedent for future global health endeavors in oncology.